A Multicenter Phase IV Study to Investigate the Immunogenicity of Recombinant Human Follicle-Stimulating Hormone and Its Impact on Clinical Outcomes in Females Undergoing Controlled Ovarian Stimulation

CONTEXT: Therapeutic proteins can cause immune responses, which may have clinical implications. AIMS: The aim of the study was to assess the immunogenicity of recombinant human follicle-stimulating hormone (r-hFSH), when used for controlled ovarian stimulation (COS). SETTINGS AND DESIGN: Prospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Majumdar, Abha, Hoang, Le, Loc, Ly T., Srivastava, Padma, Ramamurthy, Chitra, Chakravorty, Ratnabali, Nandanwar, Yogeshwar S., Rashmi, M. D, Mayekar, Rahul V., Sridhar, Jayashree, Divekar, Ganesh H., John, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937766/
https://www.ncbi.nlm.nih.gov/pubmed/32038080
http://dx.doi.org/10.4103/jhrs.JHRS_33_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937766/
https://www.ncbi.nlm.nih.gov/pubmed/32038080
http://dx.doi.org/10.4103/jhrs.JHRS_33_19

Ejemplares similares